Evaluation of the effectiveness and impact of Nirsevimab in Galicia

The study NIRSE-GAL is a joint effort between the public health authorities of Galicia (Dirección Xeral de Saude Pública, Xunta de Galicia), particularly with the epidemiology unit and research and academic institutions (Instituto de Investigación Sanitaria de Santi-ago de Compostela), particularly with the Genetic, vaccines, Infectious Diseases and Pediatrics research group (GENVIP).

Both groups agreed in the importance of doing an effectiveness evaluation for the recent inclusion of nirsevimab as part of the Galician immunization program. This collaboration ensures an analysis of effectiveness that includes the perspectives of public health, research, and clinical practice.